Our facility are located on the campus of the University Hospital of Lille, in the Research Center of the Faculty of Medicine, occupying a fully-equiped surface of 1100 m2 which is completely adapted to the development of the different scientific projects.
The "Biotherapy Platform"
The biotherapy platform is a Controlled Atmosphere Zone (CAZ) operational and legally compliant, for the production of Therapeutic Cell Therapy Preparations (PTC) for therapeutic purposes.
The structure has 250m2 of clean rooms, including two 30m2 Class D production areas with 4 microbiological Class A Laminar flow cabinets, 1 washing room and 1 room for repackaging non-disposable glassware and surgical tools to be sterilized.
The platform is validated by ANSM for clinical tests.
Director : Pr Julie Kerr-Conte
Quality engineer : Rimed Ezzouaoui
Biomedical engineer : Bruno Lukowiak
Cell therapy engineer : Sandrine Belaich
Administration : Alexandre Thévenot
We get various assistance from Lille University Hospital : Maintenance of air treatment facilities, biocleaning, biomedical tasks, control of environmental risks, financial management, and biohazard waste facilities.
We also obtain technical assistance from the Faculty of Medicine for the maintenance of facilities and equipment.
Pr F.Pattou and J.Kerr-Conte
- Human Islet of Langherans transplantations for Type 1 Diabetes treatment.
- 55 productions per year on average.
- Assistance in developing future protocols (Research & Development).
- Allowing other cell therapy teams with protocols that have already been accepted by the ANSM to use our facilities..
- Development toward cGMP norms (the structure and its activities), a requirement according to european rules for the production of new gene therapy or immunotherapy medications (MTI-PP).
An ideal geographical location
The University Hospital of Lille belongs to the largest university-hospital campus in Europe, spread over 350 hectares in Lille (the Lille-Sud neighborhood) and Loos, both part of the European Metropolis of Lille. This campus brings together the multiple institutions of CHU, the Oscar Lambret Center, as well as higher education institutions, research centers and numerous companies in the Eurasanté business park (department of excellence dedicated to biotechnology and health ). In addition to having the largest Faculty of Medicine and the largest maternity hospital ward in France, construction is currently underway to build the largest institute (by 2020) of cardiology, vascular and thoracic specialties in all of Europe.
EGID "European Genomic Institute for Diabetes"
We, along with two other units of the University of Lille, UMR 8090 (specialized in genetics) and UMR 1011 (specialized in molecular biology), founded the Research Federation EGID, which obtained the label « Laboratory of Excellence » (LABEX) in 2011.
The European Genomic Institute for Diabetes (EGID) is an international research institute dedicated to diabetes (types I and II), obesity and their respective risks. Created in February of 2009, the institute brings together three Lille research teams at an internationally recognized level.
In 2015, the unit's five-year contract was renewed, with the unit becoming the Inserm Unit 1190 "Translational Research for Diabetes" (TRD).